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0f$ztives. We tested the feasibility and elbcacy of primary 
steot implantation without Coumadin in 74 patients within 8 b of 
the onset of acute myocardhsl inhwctton. 
Bau@maf. Although stem implantation in patients with 
effort anghta provides better short- and long-term outcomes than 
ballooa angtoplasty, it is not clear whether primary stent imphut- 
tation is applica?‘le *r ehkctive in acute myocardiil infarction. 
ht2dmiv. Pkmuy stent implantation was attempted when 1) the 
Monwasnotlwa&ld&@intItemainmsincoronarybraocbes,2)tbe 
curunary artery did not sbow any severe cakikation or excessk 
bendig pmxlmal to tbe lesii on lleoroscopy, and 3) the arterial 
diimeter was 22-5 mm. The results (group Sl were compared with 
those of prhuary balloon angtoplasty (gronp P). Poststenting 
regimens contained ticlopidhte and aspirin witbout Coumadin. 
Poststenting intlation was porfotmed with 212 atm. 
I-he clinical efficacy of primary percutaneous transluminal 
coronary angioplasty for acute myocardial infarction is limited 
by the presence of reocchrsion and restenosis. The results of 
multicenter trials (l-3) of intracoronary implantation of the 
Palmaz-Schatz stent show that it is effective in the prevention 
of abrupt coronary occlusion and the reduction of the resten- 
osis rate after coronary angioplasty in angina pectoris. How- 
ever, few case .cp&s describing intracoronary stent implan- 
tation for acue ngowrdial infarction have been published 
(4-9). Al’ of the= reports dzsrihe the use of intracoronary 
stems for bailout in failed primary coronary angioplasty for 
acute myocardial infarction and slress the necessity of vigorous 
anticoagulation therapy after stenting. Recently, it was re- 
ported that intracoronary stent implantation can be performed 
safely without anticoagulation therapy if stems are fully ex- 
panded (10-13). 
The hypthesis of this study is that primary stent implanta- 
tion using the Palmaz-Schatz stent is a fc -sible reperfusion 
therapy and improves the clinical outcomes of patients with 
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Resuks. Stem implantation was successful in 72 patients. Stent 
thrombosis was noted in only one patient who ‘was not given 
ticlopidine, aspirin or Coumadin. The rates of restenosis and 
frequency of major clinical events during the hospital period in 
groups S and P were 0% versus 132% (p = 0.007) and 2&l% versus 
18.6% (p = 0.069), respectively. Kaphsn-Meier analysis demou- 
strated tbat cnmulative 90&y clinical event-free rates in proups 
P and S were 98.1 + 16.0% versus 79.4 f 43.7% (p = O.OtXiS), and 
that lSO-day rates were 865 f 3S.4% versus 64.2 2 49.7% (p = 
0.014). 
Colsrlusons. Primary stent implantation can improve clinical 
outcomes of patients with acute myocardial inhuction when the 
stent is dilated adequately and antiplatelet drugs are osed. 
(JAm Cdl cordial 19%;28:74-81) 
acute myocardial infarction without vigorous anticoagulation 
therapy if the stent is adequately deployed. 
Methods 
Before the start of this study (April 1995) the study protocol 
was examined and approved by the ethical committee of our 
hospital. The possible risks and benefits of coronary angiogra- 
phy, coronary engioplasty or stent implantation were fully 
explained to each patient and/or his or her family, and written 
consent was obtained before the patients were sent to the 
catheterization laboratory for emergent catheterization. 
DefinItioos. Primary stent implantation for acute myocar- 
dial infarction was defined as the intentional (not rescue) 
implantation of a Pahnaz-Schatz intracoronary stent 10 the 
culprit lesion of acute myocardial infarction during emergent 
catheterization within 8 h of onset. This meant that primary 
stent implantation did not include rescue stenting for intimal 
dissection or recurrent reocclusion, or both, resulting from 
coronary angioplasty or thrombolysis. Abrupt closure and 
threatened closure of the culprit lesion were defined as the 
reduction of coronary flow to Thrombolysis in Myocardial 
Infarction trial (TIh41) grade 52 respectively, during the 
emergent catheterization. Successful reperfusion was defined 
as TIM1 flow grade 3 at the end of the emergent catheteriza- 
tion. Successful primary stenting was de&red as the successful 
deployment of a Palmaz-Schatz stent to the lesion, resulting in 
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successful reperfusion. In-hospital reorlusion was defined as 
the reduction’of coronary flow to TIMI grade 52 on the 
predischarge angiogram, which was taken less t:tan 14 days 
after the onset of acute myocardial infarction. Restenosis was 
defined as an increase in percent diameter stenosis to E50%. 
Patlent selection For primay dent implaatatioa Between 
April 26,1994, and October 30,1995,143 patients who h-d an 
acute myocardial infarction within 8 h of onset were admitted 
to the Cardiology Center at Shonan Ramakura General Hos- 
pital. All of the patients were sent for emergent coronary 
angiography irrespective of age or hemodynamic status. When 
the infarct-related artery showed TIMI flow grade ~2, catheter 
intervention was attempted. Primary stent implantation was 
attempted in a subgroup (group S) of those patients, when 1) 
the culprit lesion for the acute myocardial infarction was not 
located distally in the major coronary branches, 2) the core- 
nary artery with the lesion did not show any severe calcification 
on fluoroscopy or excessive bending proximal to the lesion, 3) 
the arterial diameter was 22.5 mm, and 4) the operator was 
familiar with elective Pahnax-Schatz stent implantation and 
had performed more than 50 such pmcedures. The decision 
whether to attempt primary stent implantation was made 
immediately after taking control coronary angiograms before 
balloon inflation (usually before the insertion of a guide wire 
into the lesion). Of the 143 patients with an acute myocardial 
infarction, 7 who showed TIM1 flow grade 3 or occlusion of the 
distal coronaty artery received only coronary angiogaphy, 10 
received intracoronary thrombolysis in dosages between 24 
and 72 X 104 U of urokinase, 12 received intracoronary 
thrombolysis with urokinase and rescue coronary angioplasty, 
36 received primary coronary angioplasty without thromboly- 
sis, 4 underwent coronary artery bypass surgery because of 
severe triple-vessel disease and 74 were assigned to group S. 
Stent implantation pmcedure. When the aforemmtioned 
conditions 1 through 4 were satisfied, the patient was amigned 
to group S. In 63 patients (85%) from group S, the monorail 
technique was used for stem implantation. The baboon size 
was cacfi$ determined to be sure that its diameter at 
nominal Inflation pressure was equal to or slightly larger 
(co.25 mm) than the reference vessel diameter, which was 
estimated visually in comparison to the diameter of the guiding 
catheter. Predilation with 8 atm was performed for 530 s. A 
Palmax-Schatz stent, which was removed manually from a 
Johnson & Johnson stent delivery system, was mounted and 
tightly crimped manually to the balloon. The balloon-mounted 
stent was positioned carefully to ensure that it covered the 
initial occlusion site and dilated at 8 atm for 10 to 20 s, 
followed by postdilation at 212 atm for 20 to 30 s with the 
same balloon. If the angiograms after stenting showed intimal 
dissection near the stent, another stent was dePloyed in the 
same way. If the angiograms after stenting showed radiolu- 
cency witbin the stented segment, another balkron dilation 
with a higher pressure was added within the stem. If the 
mgiogmms after stenting showed TIM1 llow grade 2 and the 
causeofthereducedflowwasthoughttobeang@raphii 
unclear intimal dii, another stem was placed distal to 
the previous one. If the angiograms after stenting showed any 
indentation within the stent, another inflation with the same 
balloon was performed at a higher pressure until ti;a indenta- 
tion disappeared (the visual estimate of percent diameter 
stenosis should be ~5%). The typical example of primary stent 
implantaW 1‘; :‘a r‘rgr!r c I. In 21 patients (IS%) from 
group S, an over-the-wire technique was used. In this tech- 
nique, a stent was deployed using a Johnson & Johnson stent 
delivery system of an appropriate size. The method and end 
point of postdilation were similar to the monorail technique. 
Intracoronary ultrasound examination was not performed wi&h 
either technique. 
Ttirombdysii anticoegolatioa and aatiplatetet theqy. 
Ten thousand units of heparin was given at the beginn@ of 
the catheterization, and another 5,OW U was added 1 h later if 
the procedure took more than 1 h. Intracoronaty thrombolysii 
indosagesbetween24and72X 1o4Uofurokinasewasused 
before stent delivery in the lirst 16 patients of the study. None 
of the patients received thrombolysis after stent implantation. 
Intravenous heparin administration after the catbetetization 
was continued for 48 h in 29 patients. Coumadin was not 
administered to any of the patients. Oral admmistration of 
81 mg of aspirin and 1oU mg of ticlopidine three times a day 
(from April 1994 to January 1995) or twice a day (from 
February 1995 to Gctober 1995) was begun in ail patients, 
except for Patient 1, from the day of the stent implantation and 
continued for 3 months. Patient 1 was not given aspirin 
ticlopidine, Coumadin or heparin because he was known to 
have advanced gastric cancer and congruous bleedii of the 
stomach. 
Events. Intrapmcedural complications included abrupt 
closure, distal coronary embolism and side branch occlusion. 
Repeat angioplasty of the original lesion stcnt thrombosis. 
bpss surgery owing to the renarrowing of the original lesion 
and death were considered major dinical events 
Follow-op. Coronary angiogmms were taken before hospi- 
tal discharge and -3 months after stent implantation Corn- 
plete blood count, aspartate t ransanlinase and glutamic- 
pymvic transaninase were measured before dis&arge and 2 
wee~4weeksand3monthsafterdis&uge.Cli&tlfoUow-up 
was continued for more than 6 months. 
selecti oFamtml patients. From June 1992 to May 1993, 
during which time we had not yet started primary direczional 
coronary atherectomy or primary stent impkantation, 79 pa- 
tients with an acute myocardial infar&n within 8 b of onset 
wereadmittedtotheC&k9ogyCenteratShomutKamakum 
General Hospital Of these patients, 70 were treated with 
primary coronary ang&lWy, 4 were treated with intracoro 
narythrombot&switbumkbmseand5hadTIMI&avgrade3 
on the initial coronag an&gram and were managed without 
coronary interventitms. The tine films of the 70 patients who 
m&went primary cnmnary angiop&ty were carefuhy re- 
viewed by two bale-t cardii (ET. and KT.), and 
43ofthem(61%)werejudgedtomeetuberialthrough4,as 
OutIii previdy, for primary stern implantation and served 
as the control group (group P)- 
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Rgure 1. Emergent left coronary aagiogram (A! in a 69-year otd maa 
showed lhrombulysis in Myucardial Infamtioa trial Row grade 1 of the 
left anterior desceadiog coronary artery. After predilation with a 
3.25~mm balloon (B), tbe coronary angiogram showed a hazy appear 
ante at the proximal lett anterior dcsceudiig coromuy artery (C). It is 
dbhcult to determine whether it was caused by a thrombus or 
d&section. After stent implantation (D), the augiogram showed a good 
result. 
Measurements ami statistics. Vessel diameter was mea- 
sured using the automated edge-detection method, which is 
part of the Philips digital cineangiography systems (DC1 or 
Jntegris). Cahhration was done using a 7F or 8F guiding 
catheter before dye fiiling. When the automated edge- 
detection program failed to detect the outer border of the 
vessel lumen, the digital caliper that was also part of the Philips 
digital cineangiography systems was used for the measure- 
merits. The measurements of the lesion diameter were made 
during diastole using the image in a single %orst” view. 
Measurement of the reference vessel diameter was made at the 
proximal part of the vessel nearest the initial occlusion. These 
well-trained X-ray technicians working ‘mdependently from 
our group. 
Data were collected on, a relational data hose system 
created using the 4D server version l.OJ (ACI) on a Macintosh 
computer network system, and anaJyxed using EKZI version 
5.OJ (Microsoft) and Statistica version 3.015 (Stat% rft) running 
on MacOS system 7.1. Data were expressed a:% the mean 
value ? SD. Comparisons of continuous and categorical 
variables between equivalent groupS were calo,iated by the 
Student f test and Fisher exact test, respectively. Event-free 
survival rates after procedures were estimated using the 
Kaplan-Meier techniques and were displayed as standard 
survival curves. The dilTerence in event-free survival rate was 
assessed by Wilcoxon rank-sum test. 
Results 
Patient and angiegraphic charac&istics. The initial clin- 
ical angiographic characteristics of the two groups are shown in 
Table 1. Male gender, age, culprit vessel diiniution, ejection 
fraction, incidence of multivessel disease and interval between 
measurements were repeated in the images of the same view 
during follow-up angiograms. All measurements were made hy 
acute myoc&iai infarction onset and the emergent catheter- 
i&on did not differ siguificantly between the two groups. 
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Table 1. Initial Clinical Angiographic Chal’acteristics of 117 
Studv Patients 
Late outcomes. Ticlopidine was terminated within 3 weeks 
after it was started in two patients in group S owing to skin 
eruption. No patient had a ticlopidine-induced elevation of 
aspartate transaminase or glutamic-pyrwic transaminase or a 
reduction complete blood count. Of the 48 patients who 
underwent late follow-lip at&grams in group S, 8 (17%) 
showed restenosis: 7 received coronary angioplasty again and 
one underwent bypass surgery. Reocclusion was not found in 
any of the patients. Of the group P patients who did not show 
reocclusion and who did not receive repeat corcnav angle- 
plasty or bypass surgery before hospital discharge, 29 had late 
follow-up angiograms. Restenosis was found in 12 (41%) of 
them and reocclurion in 1. Repeat coronary angioplasty or 
bypass surgery, or both. were performed in 11 patients (38%). 
Kaplan-Meier analysis demonstrated that cumulative 9O-day 
major clinical event-free rates for groups P and S were 98.1 + 
16.0% and 79.4 2 43.76, respectively (p = 0.006,), and that 
Group P 
In = 431 
Group s P 
lo = 74) V&Z 
Maklfemale 34is 51/23 0.1636 
Age W 63.6 + 11.8 64.3 + Ii.8 0.757 
Lesion location: 
LAD/LCxIRCA/LMCA 21/5!17;0 36i4,14133/1 0.5492’ 
Killip clas I/lI/lII/lV 39/2/l/l 38/1w/8 o.Gw3 
LVEF 48.1 2 10.9 50.8 -t 11 .h 0.231 
Multivessel d&w 2w4 (46.5Ti) 38/74 (51.45) 0.3773 
Interval from AM1 onw 3.7 f 1.5 3.6 2 2.2 0.792 
to catheterization (hl 
‘Chi-square analysis Data presented are mean value 2 SD or number ((ii 
of patients. AM1 = acme myocardial infarction; LAD = left anterior descending 
coronary siery: LCx := left circumflex arkty; LMCA = left main coronary 
artery; LVEF = left venWicular ejection fraction; RCA = right coronary artery. 
Procedural success and complications (Table 2). In me 
patient undergoing a monorail procedure, the stent-mounted 
balloon could not reach the lesion because of proximal bending 
of the coronary artery. The stent was successfully recovered 
and successful reperfusion was achieved by primary coronary 
angioplasty. In another patient also undergoing a monorail 
procedure, the stem began to move from the initially mounted 
site on the balloon, so it was deployed proximal to the initial 
lesion, and the vessel was successful!y recanalized by primary 
corolrary angioplasty. Successful primary stenting was achieved 
in the other 72 (97%) of the 74 patients in group S. The 
poststenting inflation pressure was 14.5 ? 1.9 atm. The size of 
balloons used for the poststenting inflation was 3.33 2 0.43 mm 
at nominal inflation pressure. In those patients with successful 
deployment of stems, 61 (84%) received single stent Gnplan- 
ration and 11 received multiple s:ent implantation (9 patients 
with two stents, 1 patient with three stents and I patient with 
four stents). ScrxscFd reperfusion was achieved in all 74 
patients (100%) in group S aud 40 of the patients (9570) in 
group P. The frequency of intraprocedural complications was 
similar in the two groups. 
h-hospital outcome. One patient (Patient 2, Fig. 2) died of 
pulmonary embolism 20 days after successful stenting to the 
left main lesion. Angiograms taken before her death and an 
autopsy examination showed no stent thrombosis and a patent 
left main coronary artery. In one patient (Patient 1) emergent 
coronary angiograms showed stent thrombosis on his eighth 
hospital day, which was resolved by coronary angioplasty. After 
this event, 200 mg of ticlopidine was the only medication giver+ 
Hi recovery was uneventful and he was discharged on his 24th 
hospital day. Restenosis was not observed in any patient in 
grip S. Two of the 40 patients with successful reperfusion in 
group P did of cardiienic shock and congestive heart failure. 
Another two patients without successful rep&&ion in group P 
died of cardiogenic shock. Prqdischarge angiograms showed 
restem& in five patients and reoc&sion in three patients in 
group P. The rate of restenosis and major in-hospital events 
were significantly higher in group P thap in group S (Table 2). 
Tabtc 2. Gmmarized Dara of Groups P and S 
------- 
Group P Grrwp s
-~- 
No. of pL5 43 “4 
Successful reperfusion 4of43 (93T L 7474(3(1JGl 
Acute closure 3143 (7’2) U74WI 
Immedistely After ReperfGon 
p Value 
lJSJ43 
W43 
No. of PLF 
RVD (mm) 
MLD (mm) 
%DS 
- 
().I> 
( lLl1Jxil 
c aaJQm 
No. of pk .1x 73 
Days after AM1 new 12r.L 10 z x (1.15 
RVD (mm) 3.38 f n.*i 3.36 f 0.55 $2 
MLD (mm) I.9s f O.hl 3.117 2 11.33 C O.mIJI 
QDS 43.n 2 IX.Il X.22 2 11.6 C (J.OWJDI 
Stem thrombosii 172 (i.J’i I” 
R&e& 5 Xi (13.1; j 074 (IF; I u.uu37 
Reoc&sion 338(7.95) l,%(i.-l’i)* klI24t 
Repeat I’IUKAIIC 443(93Cl I ,74 (I ..I? )’ n.06 
In-hospital death 4’43 (9% ) I~-l(w;) kal 
Major in-hospital events 843 (x6’;) 1-M (XK) UMUY 
Or! lale Folknn-c’p .Ar@of+ram 
78 SAITOETAL 
PRIMARY !STENTlNG IN AtZUTE iMYOcARDlAL INFAXCI’ION 
JACC Vol. 28, No. 1 
July 3996~74-81 
Fire 2. A 67-year old woman (Patient 1) ar- 
rived at UL hospital with profound shock and loss 
of consciousness. Aa emergent left coronary an- 
giogram (A) showed total occlusion of the left 
main coronary artery. Primary Palmaz-Schatz 
stent implantation wrth a 3.5mm Magical Speedy 
ballcon (B) was Performed. C, Aagiogram imme- 
diately after stent implantation. D, Angiogram 11 
days after stent implantation. She died of a pul- 
monary embolism 20 days after stent implanta- 
tion. The autopsy showed no stent thrombosis. 
l&lay rates were 86.5 It 38.4% and 64.2 2 49.7%, resy~~c- 
tively (p = 0.014, Fig. 3). 
Serial angiographii variables. Reference vessel diameters 
did not diier between groups S and P in any or the three 
an&graphic studies performed during reperfuPion therapy for 
acute myocardial infarction, before discharg: and at 3-month 
follow-up. The minimal lumen diameter was greater and 
percent diameter stenosis less in group S than in group P in any 
of these three types of angiographic studies (Table 2). The 
cumulative distribution of minimal lumen diameter for both 
groups immediately after repxfusion and at predischarge 
angiography is depicted in Figure 4A. The cumulative distri- 
bution of minimal lumen dtarneter for both groups at 3-month 
follow-up angiography is shown in Figure 48. 
Discussion 
First, lumen diameter after reperfusion is thought to be 
important because reocclusion after successful thrombolysis 
occurs more often in vessels with residual stenotic cross- 
sectional areas CO.4 mm* (16) and ischemic events happen 
more often in lesions with smaller cross-sectional areas and 
larger percent diameter stenosis after elective coronary angio- 
plasty (17). Second, the presence of intimal dissection after 
coronary angioplasty is also thought to be iqortant hecause a 
major reason for closure after eleciive COiixaiy angioplasty is 
severe intimal dissection (17). Recently, primary directional 
coronary atherectomy was introduced as a reperfusion stmtegy 
Piirr 3. Comparison of Kaplan-Meier estimates of cumulative major 
clinical event-free rates for groups P and S. 
E\.z”l Free Far (7,) 
Benetits of primaq steot implantation compared with 
prinuuy coronary angtophsty. SucCessful repetfusion in acute 
myocardial infarction clearly results in myocardial salvage and 
preservation of left ventricular function and is associated with 
favorable long-term prognosis if not complicated by reocclu- 
sion of the culprit artery, which occurs often without any 
apparent symptoms (14&S). Although the cause of reocchrsion 
after successful qwfusion with primary cotonary angioplasty 
has not yet been made clear, at least two factors are involved. 
JACC Vol. 28, No. 1 
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Figure 4. Comparison of the cumulative distribution of minimnj lumen 
diameter for groups P and S immediately after reperfusion and at 
pm&charge angiography (A) and on the 3-month follow-up angio- 
gram (B). Tire numbers I, 2 and 3 indicate immediately after reper- 
fusion, at ptedixharge angiography and at 3-month follow-up angiog- 
raphy, respectively. 
for acute myocardial infarction (18). After primary directional 
coronary atherectomy, lumen diameter was observed to be 
larger both immediately after reperfusion and at predischarge 
angiography compared with after primary coronary angio- 
plasty, and this effect of primary directional coronary atherec- 
tomy was proposed as one of the mczhanisms of its t+ventwe 
et&t against reocclusion (19). Because our results also show 
that lumen diameter after primary stent implantation is well 
maintained compared with primary coronary angioplasty, 
stenting is thought to contribute to reducing the rate of 
reocclusion. Moreover, it is known to be- effective for repair of 
intimaf dissection after coronary angioplasty (1,20). From 
these considerations, it was thought that primary stent imp@ 
tation would allow a reduction in the rate of reocchtsion after 
successful reperfusion in patients with acute myocardial infarc- 
tion. 
The favorable outcomes of primary coronary angioplasty 
are also reduced by restenosis. which occurs in 31% to 45% of 
patients (21,22). As for balloon angioplasty for angina pectoris, 
it has been reported that intracnronary stent implantation 
reduces the resteuosis rate in de novo native coronary artery 
lesions (2J). It has also been shown that lumen diameter after 
Pahrmz-gchatz stent implantation is well maintained during the 
first 6 months (23). Our data show that these bewlicial effects 
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of stent implantation compared with balloon angioplasty are 
also demonstrable in acute myocardial infarction. 
Stent thrombosis and the need for vigorow antkoagulation 
tbempy. Large multicenter stuJies in patients undergoing 
elective stent implantation have reported an incidence of stent 
thrombosis of 3% to 4% (2,3,24,25). When stenting is per- 
formed for bailout or emergency indications, the incidence of 
stent thrombosis is as high as 8% to 16% (1,20,25,26). These 
results strongly support vigorous anticoagulation therapy after 
stent implantadon. However, vigorous anticoagulation therapy 
induces major bleeding complications requinng blood transfu- 
sion in 7% to ?O?J of patients (1,2.20,24). Recently. it was 
reported that the Palmaz-Schatz stent can be safely implanted 
in coronary arteries without subsequent anticoagulation ther- 
apy, provided that stent expansion is adequate and no other 
flow-limiting lesions are present (10-13). We also did not use 
anticoagulation therapy after primary stent implantation. 
However, in papers describing bailout stent implantation in 
small numbers of patients after failed or suboptimal coronary 
angioplasty during acute myocardial infarction (4-9) the need 
for vigorous anticoagulation with heparin and Coumadin or 
thrombolysis is particularly stressed. The discrepancy of anti- 
coagulation strategy after stent implantation in acute myocar- 
dial infarction between the above-referenced reports and our 
study is thought to be due to the fact that we routinely used 
poststenting inflation pressures of 212 atm, whereas the other 
investigators. routine inflations were not as high. although they 
were not fully described in all reports. 
Although intracoronaty ultrasound after stent impfantation 
is recommended to confirm the full expansion of the stent (RI), 
we did not use it after stent implantation for two reasons. First, 
we thought that the insertion of intracoronary ultrasound 
catheters after suaxssful reperfusion might induce an unnec- 
essary risk for the patient. Second, we experienced no stent 
thrombosis in more than 300 consecutive patients who had 
elective Palmaz-Schatz stent implantation with neither couma- 
din nor intracoronarv ultrasound. The end point of poststent- 
ing dilation was de&fed without intracoronary ultrasound zs 
the inflation was performed with 212 atm (usually 214 atm) 
and with considerably higher pressures when indentation was 
present within the stented segment, provided that the intimal 
dissection, if present, was completely covered by the stent(s). If 
these conditions are sat&d, the presence of intracoronary 
thrombus is not necessuily associatP.’ with stent thrombosis. 
Patient 3 is representative ot tns type 0:‘ procedure (Fig. 5). 
Need kw anti- tbeqq. One patient (Patient 1) had 
stent thrombosis 7 days after primary stent implantation. He 
dii not receive a&platelet drugs, Coumadin or heparin. In 
stenting without coumadin, the necessity of antiplatelet drug 
administration is stressed (10-12). ‘fhe cessation of antiplate- 
let regimens might have contriited to stent thrombosis. fn 
two patients in group S, antiplatelet therapy was contiuued 
with onfy as#in because bdopidii was terminated witbin 3 
weeksafteritwasstartedowiugtoskinenrptkm.IhefmXsi- 
biljty that aspirin without 6dopidine is enough for the preven- 
tion of stent thrombo& although not vet conbrmed, has been 
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Figme 5. Emergent right coronary angiogmm (A) in an 87-year old 
woman showed total occlusion. After crossing the lesion with a guide 
wire, much tbrombus was seen (it). After predilation (C), a hazy and 
irregular appearance remained. However, angiography showed a good 
result after stent implantation (D). The result was also good 10 days 
later (E). 
pointed out (10). A randomized comparison is necessary to 
determine the optimal and minimal antiplatelet regimens after 
primary stent implantation. 
Study limitations. First, this study is not a randomized 
study. Acute myocardial infarction has been generally consid- 
ered a contraindication to coronary stent implantation (3). To 
evaluate the poGiiit comical applicability of primary stent 
implantation as a reperfusion theram fat acute myocardial 
iufaretion, a pilot stxiy such as this is r,e--- isaty. The second 
limitation is that this study was conducted in a single center. 
Stent implantation requires well-trained technicians, and it is 
dithcult to find such well-trained operators at all medical 
centers. Even if primary stent implantation for acute myocar- 
dial infarction is a superior therapeutic strategy, it is a proce- 
dure which cannot be performed with sufficient skill at most 
medical centers, so it may not be clinically useful. This can only 
be determined by carrying out a multicenter study. The final 
liitation is that the data on primary coronary angioplasty 
were analyzed retrospectively and the study periods of groups 
S and P were not the same. The techniques of primary 
coronary angioplasty and the management of patients with 
acute myocardial infarction have, improved over time. This 
means that data may be biased, making the results of group P 
appear clinically worse than those of group S. The true clinical 
effectiveness, advantages or limitations of primary stent im- 
plantation will be ctified by conducting a randomized, mul- 
ticenter, prospective trial. 
Conebtsforts. On the basis of these observations, it is 
reasonable to conch& that primary Pafmaz-Schatz stent im- 
plantation for acute myocardial infarction is a clinically feasi- 
ble and effective reperfusion therapy, and that it can be 
performed without vigorous anticoagulation regimens pro- 
vided that poststenting inflation is performed with more than 
12 atm and all intimal dissections are covered with stents. 
We thank Katsumi Tam&i, MD, and Eri Tanaka, MD, for their expert help in 
preparation of the data. 
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